Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAGI Protocol: Remifentanil for general anesthesia in caesarean section in the context of prematurity
2013-001850-83Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of remifentanil in Pregnancy-related complication and preterm birth (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Apgar score at 5 minutes. Started Sep 2015; status: completed.
02
Drugs
remifentanil
03
Conditions
Pregnancy-related complicationpreterm birth
Beyond the preview
Go deeper on 2013-001850-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001850-83.